Are Your GSA Schedule Products TAA-Compliant?
Client Alert | less than 1 min read | 10.08.14
While Multiple Award Schedules administered by GSA can be a valuable tool for selling to government customers, these government-wide contracts include numerous special requirements, including the requirement that each and every product offered comply with the Trade Agreements Act restriction on providing products from so-called "non-designated countries." In "Where Are Your Products From? The Importance and Challenges of Managing TAA Compliance for GSA Schedule Holders", published in Bloomberg BNA Federal Contracts Report, C&M's Cathy Kunz and Addie Cliffe discuss recent enforcement actions that highlight the risk of TAA non-compliance and offer practical pointers for assuring compliance.
Contacts
Insights
Client Alert | 5 min read | 04.13.26
EU Pharma Package: Global (Orphan) Marketing Authorization Compromise Proposal
In our fifth alert in this EU Pharma Package Series, we provided an analysis of the background and ongoing legal debates regarding the concept of the global marketing authorization (GMA), We discussed in particular the missed opportunities in the Pharma Package to further codify and clarify the GMA, in view of its central role in determining the regulatory data protection (RDP) rights of a medicinal product.
Client Alert | 4 min read | 04.10.26
CMS Finalizes Rate Notice for Medicare Parts C and D (CY 2027)
Client Alert | 2 min read | 04.10.26
Client Alert | 4 min read | 04.10.26
FTC Issues Five-Year Strategic Plan: What Businesses Need to Know

